Growth Metrics

Veracyte (VCYT) Amortization of Deferred Charges (2016 - 2019)

Veracyte's Amortization of Deferred Charges history spans 7 years, with the latest figure at $75000.0 for Q2 2019.

  • For Q2 2019, Amortization of Deferred Charges rose 837.5% year-over-year to $75000.0; the TTM value through Mar 2020 reached $75000.0, up 134.38%, while the annual FY2019 figure was $83000.0, 159.38% up from the prior year.
  • Amortization of Deferred Charges for Q2 2019 was $75000.0 at Veracyte, up from $8000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $393000.0 in Q4 2017 and bottomed at -$34000.0 in Q4 2015.
  • The 5-year median for Amortization of Deferred Charges is $26000.0 (2017), against an average of $82000.0.
  • The largest annual shift saw Amortization of Deferred Charges crashed 139.29% in 2015 before it skyrocketed 3600.0% in 2016.
  • A 5-year view of Amortization of Deferred Charges shows it stood at -$34000.0 in 2015, then soared by 179.41% to $27000.0 in 2016, then soared by 1355.56% to $393000.0 in 2017, then plummeted by 97.96% to $8000.0 in 2018, then surged by 837.5% to $75000.0 in 2019.
  • Per Business Quant, the three most recent readings for VCYT's Amortization of Deferred Charges are $75000.0 (Q2 2019), $8000.0 (Q1 2019), and $8000.0 (Q4 2018).